Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth

These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs.

3 Stealth AI Stocks to Ride 2024’s Biggest Trend to Riches

Are you looking for the top AI stocks? Here are three under-the-radar AI stocks to ride 2024's biggest trend to riches.

Tilray (TLRY) Stock Pops on New Cannabis Drinks Brand

Tilray has been adding beverages to its line since 2021 when it acquired Sweetwater Brewing of Atlanta in the Aphria merger.

WBA Stock Alert: Walgreens Just Slashed Its Dividend

WBA is one of today's top-trending names after Walgreens slashed its dividend payout by nearly 50%. WBA stock is down 5% in premarket trading.

Why Is Evotec (EVO) Stock Down 12% Today?

Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler.

Why Is Sellas Life Sciences (SLS) Stock Down 25% Today?

Sellas Life Sciences stock is sliding lower on Thursday after the company announced a proposed public offering for shares of SLS.

Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?

Omega Therapeutics stock is rising higher on Thursday as investors in OMGA react to a search collaboration agreement with Novo Nordisk.

Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023

With the improving economy, you need to get out of these stocks to sell—the market healing does not spell good for every company.

New Year, New Gains: The 3 Best Value Stocks to Buy in 2024

With an economic recovery on the horizon, it's time to scoop up the highest quality value stocks while they remain bargains.

Dear NEXI Stock Fans, Mark Your Calendars for Jan. 18

Although NexImmune seeks to dissolve its business, NEXI stock is skyrocketing, leading to questions regarding the catalyst.

A Sick Market Benefits Healthcare Stocks

Healthcare stocks have been outperforming the broader market during the first days of trading in 2024. Is that a sign of what is to come?

The 3 Best Blue-Chip Stocks to Buy Now

These are the best blue-chip stocks to buy at attractive levels for high total returns as they represent companies with robust cash flows.

7 Most Undervalued Stocks to Buy Now

Some of the best undervalued stocks to buy are leading companies that are ready to stage big comebacks in 2023 and beyond.

The 3 Best Dividend Stocks to Buy Now 

The best dividend stocks to buy are companies increasing dividends while also generating healthy capital appreciation over time. 

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition

Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.

Why Is Dyne Therapeutics (DYN) Stock Up 39% Today?

Dyne Therapeutics stock is rising higher on Wednesday as investors in DYN react to positive clinical trial news from the company.

2 Major Reasons Why Moderna (MRNA) Stock Is Up Today

One of the most beaten-down stocks of 2023 in the biotech space, Moderna is seeing a rebound today, with MRNA stock up 15%.

3 Biotech Stocks Set for Breakthroughs in 2024

With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.

Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today?

With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications.